| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/02/2004 | WO2004074440A2 Preparation of organisms with faster growth and/or higher yield |
| 09/02/2004 | WO2004074439A2 An expression cassette and vector for transient or stable expression of exogenous molecules |
| 09/02/2004 | WO2004074431A2 Plant ion channels and related methods |
| 09/02/2004 | WO2004074430A2 Compositions, splice variants and methods relating to lung specific genes and proteins |
| 09/02/2004 | WO2004074429A2 Method for producing second-generation library |
| 09/02/2004 | WO2004074325A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | WO2004074322A1 Modified soluble t cell receptor |
| 09/02/2004 | WO2004074318A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 09/02/2004 | WO2004074311A2 Human cyclooxygenase-3 and uses thereof |
| 09/02/2004 | WO2004074310A2 Mycobacterial diagnostics |
| 09/02/2004 | WO2004074245A2 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| 09/02/2004 | WO2004073737A1 Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3 |
| 09/02/2004 | WO2004073657A2 Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases |
| 09/02/2004 | WO2004073641A2 Induced activation in dendritic cells |
| 09/02/2004 | WO2004073609A2 Posh associated kinases and related methods |
| 09/02/2004 | WO2004073604A2 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073603A2 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073390A1 Efficient gene silencing in plants using short dsrna sequences |
| 09/02/2004 | WO2004062551A3 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 09/02/2004 | WO2004058934A3 Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
| 09/02/2004 | WO2004057946A3 Method for altering the content of reserve substances in plants |
| 09/02/2004 | WO2004056968A3 Generation of plants with altered oil content |
| 09/02/2004 | WO2004056966A3 Methods of inhibiting gene expression by rna interference |
| 09/02/2004 | WO2004053135A3 Expression cassette encoding a hydroxyphenylpyruvate dioxygenase and herbicide-tolerant plants containing such a gene |
| 09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |
| 09/02/2004 | WO2004041841A3 Molecular identification of bacteria of genus streptococcus and related genuses |
| 09/02/2004 | WO2004037987A3 Secreted proteins |
| 09/02/2004 | WO2004033653A3 Gene regulation with aptamer and modulator complexes for gene therapy |
| 09/02/2004 | WO2004033470A3 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2004022702A3 Methods and reagents for identifying inhibitors of viral protease activity. |
| 09/02/2004 | WO2004020665A3 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 09/02/2004 | WO2004018627A3 Methods for propagating adenovirus and virus produced thereby |
| 09/02/2004 | WO2004016212A3 Methods and compositions for targeting secretory lysosomes |
| 09/02/2004 | WO2004015079A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/02/2004 | WO2004009779A3 Compositions and methods for the modulation of gene expression in plants |
| 09/02/2004 | WO2004005464A3 Compounds promoting delivery of genes |
| 09/02/2004 | WO2004001012A3 Plant defensins |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003100058A3 Method for creating polynucleotide molecules |
| 09/02/2004 | WO2003096981A3 Method of modulating angiogenesis |
| 09/02/2004 | WO2003093817A3 Method of identifying ligands for nuclear receptors |
| 09/02/2004 | WO2003092361A3 Temporal seed promoters for expressing genes in plants |
| 09/02/2004 | WO2003083440A3 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 09/02/2004 | WO2003076932A3 Novel method for detecting and analyzing protein interactions in vivo |
| 09/02/2004 | WO2003072813A3 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy |
| 09/02/2004 | WO2003070967A3 Highly homogeneous molecular markers for electrophoresis |
| 09/02/2004 | WO2003020915A3 Non-linear amplitude dielectrophoresis waveform for cell fusion |
| 09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
| 09/02/2004 | WO2003004689A3 Regulators of biofilm formation and uses thereof |
| 09/02/2004 | US20040172689 Recombination polypeptide for use as gene insertion tool during genic transfer; tissue engineering and the generaton of disease resistant plants |
| 09/02/2004 | US20040172688 Expression vector comprising nucleotide sequences coding internal protein fragments for use in transforming and controlling heteroolgous, tissue specific gene expression in plants |
| 09/02/2004 | US20040172687 Modified proteinase inhibitors |
| 09/02/2004 | US20040172686 Plant development regulating gene and its uses |
| 09/02/2004 | US20040172685 Method of using MAPK4 and orthologues thereof to control plant disease resistance and plant growth |
| 09/02/2004 | US20040172684 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 09/02/2004 | US20040172683 Comprises cocoa flavor peptides for improving the preparation of cocoa flavor and cocoa flavor substitutes; food processing and flavor enhancement |
| 09/02/2004 | US20040172682 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 09/02/2004 | US20040172681 Trangenic plant with enhanced phosphopantetheine:protein transferase and fatty acid sythase activity for increasing concentration of oils in plant tissue; tissue engineering |
| 09/02/2004 | US20040172680 Process for modifying plants |
| 09/02/2004 | US20040172679 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/02/2004 | US20040172678 Using transformation via expression vectors to generate transgenic weeds with modified propagation activities |
| 09/02/2004 | US20040172677 Transgenic peas, tomatoes or beans comprising vector coding nucleotide sequences associated with glutamate glyoxylate aminotransferase activity for use in generating plants with enhanced gluamate concentrations |
| 09/02/2004 | US20040172676 Transforming cells with expression vector comprising early nodulin gene-2 (ENOD2) promoter for use as tissue specific gene regulatory tool; bioreactors and heterologous gene expression |
| 09/02/2004 | US20040172675 using a D-specific enoyl-CoA hydratase gene in genetically engineered klebsiella, aeromonas, clostridium, and escherichia |
| 09/02/2004 | US20040172674 Expression vector comprising nucleotide sequences coding enzymatic polypeptide associated with phenylpropanoid biosynthesis pathway for enhancing isoflavone content in seeds of transgenic plants |
| 09/02/2004 | US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants |
| 09/02/2004 | US20040172672 Method for producing transgenic monocotyledonous plants |
| 09/02/2004 | US20040172671 Transformed dicotyledon comprising nucleotide sequences coding cercropin lytic toxin which prevents parasitic infection of root system |
| 09/02/2004 | US20040172670 Maize yellow stripe1 and related genes |
| 09/02/2004 | US20040172669 Transgenic herbicide resistant sugarbeet with enhanced growth, yield, quality and pathogen resistance |
| 09/02/2004 | US20040172667 Administration of transposon-based vectors to reproductive organs |
| 09/02/2004 | US20040172666 Transgenic birds and method of producing protein using same |
| 09/02/2004 | US20040172665 Compositions and methods for treating enzyme deficiency |
| 09/02/2004 | US20040171826 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | US20040171825 Human fibroblast growth factor-related compositions |
| 09/02/2004 | US20040171824 Expression vector comprising nuclear localization signal for use as tool in heterologous gene transfer, propagation and induction in mammalian cells |
| 09/02/2004 | US20040171822 Methods for determining ring number in carotenoids by lycopene epsilon-cyclasses and uses thereof |
| 09/02/2004 | US20040171820 To be used in hybridization methods, for the determination of a nucleic acid |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171813 comprises homogenizing to produce a green juice, adjusting pH and heating, separating by centrifugation and/or resuspension, then chromatography |
| 09/02/2004 | US20040171812 found in natural rubber that can induce an allergic reaction in persons who have been sensitised to it; for determining molecular weight, isoelectric point, amino acid sequence and allergenicity; for immunoassay/therapy |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171810 used to find a novel protein linked to the cytomatrix and considered to play an important role in synaptogenesis |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 09/02/2004 | US20040171805 including prevention and treatment of microbial diseases, diagnostic assays for detecting infection; for drug screening vaccines; genetic engineering |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
| 09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171800 Gamma retinoic acid receptor |
| 09/02/2004 | US20040171795 capable of binding to a gene and transferring this gene into cells, have an affinity with phosphatidylserine, have a high safety and an excellent selectivity; for gene therapy/cancer treatment; genetic engineering |
| 09/02/2004 | US20040171575 Antisense modulation of interferon gamma receptor 2 expression |
| 09/02/2004 | US20040171573 Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy |
| 09/02/2004 | US20040171571 5' CpG nucleic acids and methods of use |
| 09/02/2004 | US20040171570 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/02/2004 | US20040171569 that directs formation of a recombinant virus upon introduction into a cell |
| 09/02/2004 | US20040171568 oligonucleotide at least 29 nucleotides in length, wherein the anti-HIV activity of said oligonucleotide occurs principally by a non-sequence complementary mode of action |